BioStar Ventures is a venture capital partnership created by physicians and medical business leaders to invest primarily in early stage medical devices. BioStar was formed in 2003 by Managers and Scientific Advisory Board Members who have proven track records within the medical device industry. BioStar’s unique marriage of world renowned clinicians with experienced venture capitalists allows BioStar to capture unique deal flow and leverage decades of scientific knowledge, clinical expertise, and patient care delivery experience to benefit its investment process. Our limited partners include seasoned medical device senior executives as well as major medical device companies.
BioStar prefers to invest in the cardiovascular, orthopedic, neuroscience, and gastroenterology clinical specialties. BioStar also is interested in looking at biomaterials and how they can be used in any type of clinical area. We prefer to invest in a company where it can leverage the clinical expertise of the BioStar team. Often in a BioStar portfolio company, one of the medical venture partners or advisors also might be asked to serve on the company’s SAB. BioStar encourages this as we believe our clinical expertise can only expedite a company’s success.
If appropriate BioStar will serve as lead investor but follow on invests as well. Our initial investment in a company ranges from $250K - $3 million, depending upon the technology and stage of a company’s development. We intend to support our portfolio companies in their follow on financing rounds through time of exit. Accordingly, BioStar invests between $2 - $6 million over the life of an investment.